| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KIN | Common Stock | Disposed to Issuer | -$1.35M | -146K | -100% | $9.25 | 0 | Aug 27, 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$170K | -20.4K | -100% | $8.35 | 0 | Aug 27, 2021 | Common Stock | 20.4K | $0.90 | By SD Scientific, Inc. | F2, F3 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$757K | -96.1K | -100% | $7.88 | 0 | Aug 27, 2021 | Common Stock | 96.1K | $1.37 | Direct | F4 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | $0 | -75K | -100% | $0.00* | 0 | Aug 27, 2021 | Common Stock | 75K | $15.41 | Direct | F5 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$135K | -59K | -100% | $2.29* | 0 | Aug 27, 2021 | Common Stock | 59K | $6.96 | Direct | F6 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$342K | -59K | -100% | $5.80 | 0 | Aug 27, 2021 | Common Stock | 59K | $3.45 | Direct | F7 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$170K | -30K | -100% | $5.65 | 0 | Aug 27, 2021 | Common Stock | 30K | $3.60 | Direct | F8 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$285K | -100K | -100% | $2.85 | 0 | Aug 27, 2021 | Common Stock | 100K | $6.40 | Direct | F9 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$50K | -100K | -100% | $0.50* | 0 | Aug 27, 2021 | Common Stock | 100K | $8.75 | Direct | F10 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | $0 | -75K | -100% | $0.00* | 0 | Aug 27, 2021 | Common Stock | 75K | $12.60 | Direct | F11 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | $0 | -150K | -100% | $0.00* | 0 | Aug 27, 2021 | Common Stock | 150K | $9.91 | Direct | F12 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | $0 | -80K | -100% | $0.00* | 0 | Aug 27, 2021 | Common Stock | 80K | $9.84 | Direct | F13 |
| transaction | KIN | Stock Option (right to buy) | Disposed to Issuer | -$221K | -46K | -100% | $4.81 | 0 | Aug 27, 2021 | Common Stock | 46K | $4.44 | Direct | F14 |
Denise Bevers is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Represents 145,835 shares of common stock that were disposed of at the effective time of the merger (the "Merger") contemplated by the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement") in exchange for a cash payment of $9.25 per share. The amount of securities includes 2,000 shares of Kindred Biosciences, Inc. common stock that were inadvertently omitted from previous Form 4 filings after being acquired by the reporting person pursuant to the Kindred Biosciences, Inc. Employee Stock Purchase Plan. |
| F2 | This option, which vested 25% of the total number of shares underlying the option ("Option Shares") on the annual anniversary of August 29, 2013, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $170,340.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
| F3 | Held by SD Scientific, Inc. ("SD Scientific"). The Reporting Person is a co-director and co-stockholder of SD Scientific, and as such, shares voting and dispositive power over such shares held by SD Scientific but disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein. |
| F4 | This option, which vested 25% of the total number of shares underlying the option ("Option Shares") on the annual anniversary of August 29, 2013, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $757,204.96, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
| F5 | This option, which vested 25% of the Option Shares on the annual anniversary of February 3, 2014, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for no consideration. |
| F6 | This option, which vested 25% of the Option Shares on the annual anniversary of January 26, 2015, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $135,180.99, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
| F7 | This option, which vested 25% of the Option Shares on the annual anniversary of January 8, 2016, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $342,379.80, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
| F8 | This option, which vested 25% of the Option Shares on the annual anniversary of April 5, 2016, with the remaining Option Shares vested in equal monthly installments over the following three years, subject to continued employment on each such vesting date, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $169,500.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
| F9 | This option, which was subject to acceleration of vesting pursuant to a severance and release agreement between Kindred Biosciences, Inc. and the reporting person, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $285,000.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
| F10 | This option, which was subject to acceleration of vesting pursuant to a severance and release agreement between Kindred Biosciences, Inc. and the reporting person, was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $50,000.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |
| F11 | This option, which was subject to acceleration of vesting pursuant to a severance and release agreement between Kindred Biosciences, Inc. and the reporting person, was cancelled pursuant to the Merger Agreement in exchange for no consideration. |
| F12 | This option, which was subject to acceleration of vesting pursuant to a severance and release agreement between Kindred Biosciences, Inc. and the reporting person, was cancelled pursuant to the Merger Agreement in exchange for no consideration. |
| F13 | This option, which was subject to acceleration of vesting pursuant to a severance and release agreement between Kindred Biosciences, Inc. and the reporting person, was cancelled pursuant to the Merger Agreement in exchange for no consideration. |
| F14 | This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $221,260.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share. |